Chemfab Alkalis Publishes Q2 & H1 FY26 Unaudited Financial Results
Chemfab Alkalis published its Q2 & H1 FY26 unaudited standalone and consolidated financial results. Standalone profit decreased, and consolidated net loss widened for the period ended September 30, 2025.
Financial results are a key indicator of a company's performance and directly influence investor sentiment and market valuation. The reported decline in profitability is a significant event.
The company reported a decrease in standalone net profit and a significant increase in consolidated net loss for the quarter and half-year ended September 30, 2025, compared to the previous year's corresponding period.
Chemfab Alkalis Limited has published its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025, in compliance with Regulation 47 of SEBI (LODR) Regulations, 2015. The advertisements were published in Business Standard (English Newspaper) and Makkal Kural (Tamil Newspaper) on November 1, 2025.
* Standalone Financial Highlights (Quarter Ended September 30, 2025): * Total Income from operations: ₹717.53 lakh * Net Profit for the period (after tax): ₹159.22 lakh * Basic Earnings per Share (EPS): ₹1.11
* Consolidated Financial Highlights (Quarter Ended September 30, 2025): * Total Income from operations: ₹783.19 lakh * Net Loss for the period (after tax): (₹201.07) lakh * Basic Earnings per Share (EPS): (₹1.40)
The full detailed financial results are accessible on the websites of BSE, NSE, and the company.
What to do with a filing like this
Chemfab Alkalis Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Chemfab Alkalis Limited. Read the original for the full detail.